Review of central haemodynamic effects of alpha-blockers and their future use in hypertension
Omvik, P.; Lund-Johansen, P.
British journal of clinical practice. Supplement 54: 15-21
1987
ISSN/ISBN: 0262-8767 PMID: 2905158 Document Number: 290560
Document emailed within 1 workday
Related Documents
Nelson, G.I.; Hussain, M.; Forsyth, D.; Wilson, J.; Silke, B.; Taylor, S.H. 1984: Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension Journal of Cardiovascular Pharmacology 6(1): 176-181Tarazi, R.C.; Dustan, H.P.; Bravo, E.L. 1976: Haemodynamic effects of propranolol in hypertension: a review Postgraduate Medical Journal 52(Suppl 4): 92-100
Coutts, L.C. 1997: Alpha blockers, diuretics and beta blockers for hypertension American Family Physician 55(7): 2431
Jacob, B.G.; Richter, W.O.; Schwandt, P. 1993: Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators Fortschritte der Medizin 111(8): 126-129
Zusman, R.M. 2000: The role of alpha 1-blockers in combination therapy for hypertension International Journal of Clinical Practice 54(1): 36-40
Asmar, R.G.; Pannier, B.; Laurent, S.T.; Benetos, A.; Daou, J.; Safar, M. 1990: Haemodynamic effects of perindopril in essential hypertension Journal of Human Hypertension 4(Suppl 4): 35-43; Discussion 44
Taraphder, A. 2014: Alpha Adrenergic Blockers in the Treatment of Hypertension--A Nephrologist's Perspective Journal of the Association of Physicians of India 62(9 Suppl): 30-33
Phadke, A.S. 1998: Metabolic effects of alpha-blockers Journal of the Association of Physicians of India Suppl 1: 15-21
Kishi, Y.; Okumura, F.; Furuya, H. 1984: Haemodynamic effects of nicardipine hydrochloride. Studies during its use to control acute hypertension in anaesthetized patients British Journal of Anaesthesia 56(9): 1003-1007
Glezer, G.A.; Moskalenko, N.P.; Megrelishvili, R.I.; Zilbert, N.L. 1976: Effects of propranolol on haemodynamic changes and gas exchange at rest, in orthostasis, and on exercise in patients with arterial hypertension Cor et Vasa 18(1): 26-41
Stokes, G.S. 1988: Age-related effects of antihypertensive therapy with alpha-blockers Journal of Cardiovascular Pharmacology 12(Suppl 8): S109-S115
Hardin, J.M.; Andrejak, M.; Makdassi, R.; Gherbrand, J.D.; Fievet, P.; Schmit, J.L.; Roger, J.C.; Harichaux, P.; Kassouf, J.; Fournier, A. 1981: Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 117-124
Robles, N.R. 2000: Central agents in arterial hypertension: back to the future Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 20(4): 302-310
Schiffrin, E.L. 2002: Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers Canadian Journal of Cardiology 18 Suppl A: 15a-18a
Omvik, P.; Lund-Johansen, P. 1988: Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension Annals of Clinical Research 20(Suppl 48): 23-30
Ekbom, T.; Dahlöf, B.; Hansson, L.; Lindholm, L.H.; Scherstén, B.; Wester, P.O. 1992: Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study Journal of Hypertension 10(12): 1525-1530
Zeng, K. 1991: Dysfunction of the central nervous alpha-adrenergic receptors in patients with essential hypertension Zhonghua Xin Xue Guan Bing Za Zhi 19(4): 222-224
Held, P.H.; Yusuf, S. 1993: Effects of beta-blockers and calcium channel blockers in acute myocardial infarction European Heart Journal 14(Suppl): 18-25
2003: 5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked MMW Fortschritte der Medizin 145(27-28): 58-59
Stokes, G.S.; Marwood, J.F. 1984: Review of the use of alpha-adrenoceptor antagonists in hypertension Methods and Findings in Experimental and Clinical Pharmacology 6(4): 197-204